QCG
AGL icon

Quadrant Capital Group’s Agilon Health AGL Stock Holding History

Quadrant Capital Group’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-17
Closed -$440 – 2709
2025
Q3 		$440 Sell
17
-568
-97% -$21.5K ﹤0.01% 2628
2025
Q2 		$33.6K Buy
585
+114
+24% +$9.14K ﹤0.01% 1332
2025
Q1 		$51K Buy
471
+388
+467% +$33.8K ﹤0.01% 1713
2024
Q4 		$3.96K Sell
83
-164
-66% -$9.91K ﹤0.01% 2362
2024
Q3 		$24.2K Sell
247
-159
-39% -$20.5K ﹤0.01% 1815
2024
Q2 		$66.3K Buy
406
+202
+99% +$28.8K ﹤0.01% 1255
2024
Q1 		$31.1K Buy
204
+200
+5,000% +$33.3K ﹤0.01% 1648
2023
Q4 		$1.18K Sell
4
-39
-91% -$14.1K ﹤0.01% 2539
2023
Q3 		$18.9K Buy
43
+36
+514% +$16.3K ﹤0.01% 1737
2023
Q2 		$3.1K Buy
7
+2
+40% +$1.12K ﹤0.01% 2316
2023
Q1 		$2.85K Buy
5
+4
+400% +$2.24K ﹤0.01% 2360
2022
Q4 		$323 Buy
+1
New +$469 ﹤0.01% 2663
2022
Q1 		– Sell
-1
Closed -$1K – 2477
2021
Q4 		$1K Buy
+1
New +$608 ﹤0.01% 2231

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NPCM
North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Quadrant Capital Group's AGL Position: Q4 2025 in Review

Quadrant Capital Group sold out of Agilon Health (AGL) in Q4 2025, closing a stake of 17 shares — an estimated $440 sold.

Quadrant Capital Group first reported a position in AGL in Q4 2021 and held it in 13 quarters. The position peaked at $66.3K in Q2 2024. 194 funds tracked by Wall St. Rank hold AGL as of Q4 2025.

  • Quadrant Capital Group reported no remaining Agilon Health position as of Q4 2025 after selling out during the quarter.
  • Quadrant Capital Group sold 17 Agilon Health shares in Q4 2025, an estimated $440.
  • Quadrant Capital Group first reported a position in Agilon Health in Q4 2021 and held it in 13 quarters.
  • Quadrant Capital Group's Agilon Health position peaked at $66.3K in Q2 2024.
  • 194 funds tracked by Wall St. Rank held Agilon Health as of Q4 2025.

Based on Quadrant Capital Group's 13F filing for Q4 2025, filed 13 Feb 2026.